0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 101-120 of 665 Articles
JAMA | 
From the JAMA Network | 
Cindy England Owen, MD
JAMA. 2014;311(20):2121-2122. doi:10.1001/jama.2014.2323.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(20):2057. doi:10.1001/jama.2014.5759.

JAMA | 
Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(20):2056. doi:10.1001/jama.2014.5899.

JAMA | 
Editorial | 
Donald C. Goff, MD
JAMA. 2014;311(19):1973-1974. doi:10.1001/jama.2014.4311.

JAMA | 
Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(19):1955-1956. doi:10.1001/jama.2014.4461.

JAMA | 
From the JAMA Network | 
Kimford J. Meador, MD
JAMA. 2014;311(17):1797-1798. doi:10.1001/jama.2014.967.

JAMA | 
Preliminary Communication | 
Flor M. Munoz, MD; Nanette H. Bond, PAC; Maurizio Maccato, MD; et al.
JAMA. 2014;311(17):1760-1769. doi:10.1001/jama.2014.3633.
Includes: Supplemental Content

JAMA Dermatology | 
Editorial | 
Kenneth A. Katz, MD, MSc, MSCE; Erika E. Reid, MD; Mary-Margaret Chren, MD
JAMA Dermatol. 2014;150(5):483-485. doi:10.1001/jamadermatol.2013.9711.

JAMA Ophthalmology | 
Original Investigation | 
Juan Ding, PhD; David A. Sullivan, PhD
JAMA Ophthalmol. 2014;132(5):593-599. doi:10.1001/jamaophthalmol.2013.8295.

JAMA Internal Medicine | 
Original Investigation | 
Jane A. Gwira Baumblatt, MD; Caleb Wiedeman, MPH; John R. Dunn, DVM, PhD; et al.
JAMA Intern Med. 2014;174(5):796-801. doi:10.1001/jamainternmed.2013.12711.

JAMA Neurology | 
Original Investigation | 
Elliot M. Frohman, MD, PhD; Maria Chiara Monaco, PhD; Gina Remington, RN; et al.
JAMA Neurol. 2014;71(5):596-602. doi:10.1001/jamaneurol.2014.63.

JAMA Neurology | 
Original Investigation | 
The Parkinson Study Group QE3 Investigators
JAMA Neurol. 2014;71(5):543-552. doi:10.1001/jamaneurol.2014.131.
Includes: Supplemental Content

JAMA Dermatology | 
Notable Notes | 
Walter H. C. Burgdorf, MD
JAMA Dermatol. 2014;150(5):534. doi:10.1001/jamadermatol.2013.10442.

JAMA Neurology | 
Original Investigation | 
Wendy K. M. Liew, MBChB, MRCPCH; Christine A. Powell, MA; Steven R. Sloan, MD, PhD; et al.
JAMA Neurol. 2014;71(5):575-580. doi:10.1001/jamaneurol.2014.17.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Sei J. Lee, MD, MAS
JAMA Intern Med. 2014;174(5):686-688. doi:10.1001/jamainternmed.2013.13307.

JAMA Internal Medicine | 
Original Investigation | 
Andrew I. Geller, MD; Nadine Shehab, PharmD, MPH; Maribeth C. Lovegrove, MPH; et al.
JAMA Intern Med. 2014;174(5):678-686. doi:10.1001/jamainternmed.2014.136.
Includes: Supplemental Content

JAMA Internal Medicine | 
Viewpoint | 
Scott A. Flanders, MD; Sanjay Saint, MD, MPH
JAMA Intern Med. 2014;174(5):661-662. doi:10.1001/jamainternmed.2014.897.

JAMA Dermatology | 
Observation | 
Daniel N. Cohen, MD, PhD; Wilfred A. Lumbang, MD; Alan S. Boyd, MD; et al.
JAMA Dermatol. 2014;150(5):575-577. doi:10.1001/jamadermatol.2013.7784.
Includes: Supplemental Content

JAMA Dermatology | 
Research Letter | 
Ville Kiiski, MD; Anita Remitz, MD, PhD; Sakari Reitamo, MD, PhD; et al.
JAMA Dermatol. 2014;150(5):571-574. doi:10.1001/jamadermatol.2013.7016.
Includes: Supplemental Content

JAMA | 
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(16):1600. doi:10.1001/jama.2014.4483.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Perspective  | 
Statin-Related Cognitive Impairment in the Real World:  You’ll Live Longer, but You Might Not Like It
Jonathan McDonagh
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Internal Medicine
Original Investigation  | 
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS